Vernalis (Apokyn & Vernalis US Commercial Operations) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Vernalis (Apokyn & Vernalis US Commercial Operations) General Information
Description
Developer of pharmaceutical products headquartered in Wokingham, England. The company develops and applies fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives, inflammation and integrates fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive synthetic organic and medicinal chemistry expertise to enable drug discovery on both established and novel targets.
Contact Information
Corporate Office
- Oakdene Court, 613 Reading Road
- Winnersh
- Wokingham RG41 5UA
- England, United Kingdom
Corporate Office
- Oakdene Court, 613 Reading Road
- Winnersh
- Wokingham RG41 5UA
- England, United Kingdom
Vernalis (Apokyn & Vernalis US Commercial Operations) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Vernalis (Apokyn & Vernalis US Commercial Operations) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Vernalis (Apokyn & Vernalis US Commercial Operations) FAQs
-
Where is Vernalis (Apokyn & Vernalis US Commercial Operations) headquartered?
Vernalis (Apokyn & Vernalis US Commercial Operations) is headquartered in Wokingham, United Kingdom.
-
What industry is Vernalis (Apokyn & Vernalis US Commercial Operations) in?
Vernalis (Apokyn & Vernalis US Commercial Operations)’s primary industry is Drug Discovery.
-
Is Vernalis (Apokyn & Vernalis US Commercial Operations) a private or public company?
Vernalis (Apokyn & Vernalis US Commercial Operations) is a Private company.
-
What is the current valuation of Vernalis (Apokyn & Vernalis US Commercial Operations)?
The current valuation of Vernalis (Apokyn & Vernalis US Commercial Operations) is
. -
What is Vernalis (Apokyn & Vernalis US Commercial Operations)’s current revenue?
The current revenue for Vernalis (Apokyn & Vernalis US Commercial Operations) is
. -
Who are Vernalis (Apokyn & Vernalis US Commercial Operations)’s investors?
Vernalis has invested in Vernalis (Apokyn & Vernalis US Commercial Operations).
-
When was Vernalis (Apokyn & Vernalis US Commercial Operations) acquired?
Vernalis (Apokyn & Vernalis US Commercial Operations) was acquired on 01-Jul-2008.
-
Who acquired Vernalis (Apokyn & Vernalis US Commercial Operations)?
Vernalis (Apokyn & Vernalis US Commercial Operations) was acquired by Ipsen (Pharmaceuticals).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »